Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$606,036
+$9,242 QoQ
Shares Held
3,867
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#805
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dakota Wealth Management holds $173,563,596 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,782 | $57,311,169 | |
| 2 | MRK |
Merck & Co., Inc.
|
250,026 | $32,128,341 | |
| 3 | JNJ |
Johnson & Johnson
|
98,608 | $25,043,473 | |
| 4 | AMGN |
Amgen Inc
|
48,550 | $17,580,926 | |
| 5 | ABBV |
AbbVie Inc.
|
53,370 | $13,430,026 | |
| 6 | BIIB |
Biogen Inc.
|
47,326 | $10,225,255 | |
| 7 | PFE |
Pfizer Inc
|
390,045 | $9,392,283 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
41,150 | $5,198,891 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $606,036 | 3,867 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $596,794 | 3,907 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $646,610 | 4,690 | Shares | Defined | 2026-01-13 | |
| 2025-09-30 | $574,002 | 4,476 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $731,989 | 6,049 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $674,676 | 6,052 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $617,431 | 6,345 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $749,240 | 6,514 | Shares | Defined | 2024-10-23 | |
| 2024-06-30 | $686,241 | 6,446 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $637,160 | 6,587 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $838,555 | 8,305 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $859,290 | 8,436 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $709,598 | 7,032 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $657,156 | 7,143 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $682,667 | 7,525 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $581,856 | 7,655 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $538,455 | 6,370 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $427,254 | 4,869 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $409,709 | 4,684 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $403,419 | 4,933 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $450,999 | 4,943 | Shares | Other | 2021-08-02 | |
| 2021-03-31 | $394,147 | 4,611 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $434,471 | 4,601 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $413,494 | 4,755 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $406,217 | 4,651 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $383,474 | 4,651 | Shares | Other | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||